1. Home
  2. ARWR vs NYT Comparison

ARWR vs NYT Comparison

Compare ARWR & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

N/A

Current Price

$58.19

Market Cap

10.1B

Sector

Health Care

ML Signal

N/A

Logo New York Times Company (The)

NYT

New York Times Company (The)

N/A

Current Price

$78.58

Market Cap

11.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
ARWR
NYT
Founded
2003
1851
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
11.5B
IPO Year
2009
1994

Fundamental Metrics

Financial Performance
Metric
ARWR
NYT
Price
$58.19
$78.58
Analyst Decision
Strong Buy
Buy
Analyst Count
10
6
Target Price
$81.50
$67.33
AVG Volume (30 Days)
1.9M
2.4M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
1.17%
EPS Growth
99.80
18.08
EPS
0.22
2.09
Revenue
$16,142,321.00
$1,783,639,000.00
Revenue This Year
N/A
$10.40
Revenue Next Year
N/A
$6.35
P/E Ratio
$269.95
$37.87
Revenue Growth
N/A
N/A
52 Week Low
$10.66
$44.83
52 Week High
$76.76
$82.74

Technical Indicators

Market Signals
Indicator
ARWR
NYT
Relative Strength Index (RSI) 36.19 56.46
Support Level $36.34 $69.30
Resistance Level $66.37 N/A
Average True Range (ATR) 3.00 2.10
MACD -0.49 -0.09
Stochastic Oscillator 13.32 53.42

Price Performance

Historical Comparison
ARWR
NYT

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.

Share on Social Networks: